Funding typesShareholder Investment

Products 11 to 20 of 129

Artemisinic Acid by Amyris
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: USA + Africa + France
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Input
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Bio-based 1,4 Butanediol by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:28 (5 years ago)
Known funding amount: 3,000,000 CAN
Funding types: Debtor-in-possession financing + Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Bio-based Disodium Succinate by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:28 (5 years ago)
Known funding amount: 3,000,000 CAN
Funding types: Debtor-in-possession financing + Shareholder Investment
Industry: Food & Agriculture
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: NASEM Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Bio-DEMâ„¢ by Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components: Enzyme + Gene Editing + Microbe + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:33 (5 years ago)
Date last modified: 2019/09/12 14:33 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment + Venture Capital
Industry: Industrial + Multipurpose
Market status: On the market
Organization type(s): Private Company
Product categories: Additive + Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:28 (5 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:29 (5 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Personal Care
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product
BIO-SA Based Phthalate-Free Plasticizers by LANXESS + BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: Germany
Country of distribution: USA + Germany
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/09 16:28 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: LXS (XETRA)
Value chain stage: N/A
BIO-SA Based Polyurethanes by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:29 (5 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
BIO-SA Based Resins & Coatings by BioAmber, Inc.
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: Benelux + France + Iberia + Germany + Poland + Switzerland + UK + Ireland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:30 (5 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product